Determining Product Value Proposition

For a novel injectable product administered initially in the acute hospital setting, Analysis Group conducted extensive interviews with managed care plan pharmacy and medical directors and case managers, and with hospital pharmacy directors, nursing, and other staff. We profiled the relative importance of the drug’s attributes, how those attributes mapped to key stakeholders, and how important those factors would be in determining its likely position in hospital protocols and managed care formularies under various competitive scenarios.